logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: Medicine
Load new posts () and activity
Like Reblog Comment
text 2018-11-15 09:44
OTC Cough, Cold and Allergy Medicine Market Estimated to Record Highest during by 2025

Market Overview:

Over the cough are the products which are used to relieve symptoms of cold, flu, and allergy, including nasal stuffiness and congestion, sneezing, runny noses, sore throat, and cough. The main causes of these symptoms are common cold, influenza virus, allergic rhinitis, fever and sinus infections. Global OTC Cough, Cold & Allergy Medicine Market is expected to grow in the forecasted period, in 2017 market size of the OTC Cough, Cold & Allergy Medicine was XX million and in 2025 is expected to reach at XX million with growing CAGR of XX%.

Market Dynamics:

Factor such as government initiatives, better healthcare facilities and increasing number of immunosuppressed individuals which are expected to boost the growth of the OTC Cough, Cold & Allergy Medicine Market. Furthermore, rising global geriatric population, laws enforcing consumer safety and increasing usage of cold & cough medications for minor issues is expected to boost the growth of the overall market. However, costs & prices with manufacturing process of the product are expected to hinder the growth of the OTC Cough, Cold & Allergy Medicine Market over the forecast period.

Request For Report Sample: https://www.researchreportinsights.com/report/upsample/120124650/OTC-Cough%2c-Cold-and-Allergy-Medicine-Market

Market Players:

Sanofi-Aventis, Johnson & Johnson Service, Inc., Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZaneca Plc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Prestige Brands Holdings, Inc., Procter & Gamble Co., Bristol-Myers Squib Co., Merck & Co., and Allergenare some of the prominent players in the OTC Cough, Cold & Allergy Medicine Market.

Market Segmentation:

Asia-Pacificexpected to grow with a fastest CAGR over forecast period majorly due to government initiatives, dropping air quality which results in increase in pollution and higher occurrence of respiratory ailments.  Furthermore, rapid adoption of OTC medicines ,convenience of purchase and cost-efficiency is also expected to boost the growth of the overall market in this region.Countries such as China and Japan are expected to account for the largest market share over the forecast period.

Pharmacies segment of sales channel dominated the market in 2017 majorly due toincreasing sales of allergy, cold & cough drugs.

Market segmented on the basis ofdrugtype:

• Antihistamine

• Expectorants

• Bronchodilators

• Antibiotics

• Others

Request For Report TOC : https://www.researchreportinsights.com/report/TOC/120124650/OTC-Cough,-Cold-and-Allergy-Medicine-Market

Market segmented on the basis ofsales channel:

• Pharmacy

• Online

• Modern Trade

• Drug Store

• Others

Market segmented on the basis ofdosage:

• Liquid

• Capsule

• Tablet

• Lozenges

• Others

Market segmented on the basis of region:

- North America

• US

• Canada

• Mexico

- Europe

• UK

• Germany

• France

• Rest of Europe

- Asia-Pacific

• China

• Japan

• India

• Australia

• Rest of Asia-Pacific

- Latin America

• Brazil

• Rest of Latin America

- Middle East and Africa (MEA)

• South Africa

• Saudi Arabia

• Rest of MEA

Report Analysis: https://www.researchreportinsights.com/report/upcomming/120124650/OTC-Cough%2c-Cold-and-Allergy-Medicine-Market

About Us                               

Research Report Insights (RRI) is a leading market intelligence and consulting firm. We deliver a host of services including custom research reports, syndicated research reports, and consulting services which are personalised in nature. RRI delivers a complete packaged solution to clients; this combines current market intelligence, technology inputs, statistical anecdotes, valuable growth insights, 360-degree view of the competitive framework, and anticipated market trends

Like Reblog Comment
text 2018-11-09 06:21
Allergy Medicine Market increasing demand with Industry Professionals at 2025

November 09, 2018: In 2017, the global Allergy Medicine market size was  million US$ and is forecast to  million US in 2025, growing at a CAGR of  from 2018. The objectives of this study are to define, segment, and project the size of the Allergy Medicine market based on company, product type, application and key regions.

 

This report studies the global market size of Allergy Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Allergy Medicine in these regions.

 

This research report categorizes the global Allergy Medicine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

 

Download sample Copy of This Report at: https://www.radiantinsights.com/research/global-allergy-medicine-market-insights-forecast-to-2025/request-sample

 

The various contributors involved in the value chain of Allergy Medicine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Allergy Medicine include

  • Sanofi
  • Johnson & Johnson
  • Bayer
  • Matrixx Initiatives
  • AstraZeneca
  • GSK
  • Pfizer
  • Chattem

View Full Report with TOC @ https://www.radiantinsights.com/research/global-allergy-medicine-market-insights-forecast-to-2025

 

The study objectives of this report are:

  • To study and analyze the global Allergy Medicine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
  • To understand the structure of Allergy Medicine market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Allergy Medicine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Allergy Medicine with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To project the value and volume of Allergy Medicine submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

 

In this study, the years considered to estimate the market size of Allergy Medicine are as follows:

  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Allergy Medicine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

 

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

 

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

 

For More Information, Visit Radiant Insights

 

Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com    
Blog URL: http://consumergoods691.wordpress.com

Like Reblog Comment
text 2018-11-06 07:08
OTC Cough, Cold and Allergy Medicine Market Estimated to Record Highest during by 2025

Market Overview:

Over the cough are the products which are used to relieve symptoms of cold, flu, and allergy, including nasal stuffiness and congestion, sneezing, runny noses, sore throat, and cough. The main causes of these symptoms are common cold, influenza virus, allergic rhinitis, fever and sinus infections. Global OTC Cough, Cold & Allergy Medicine Market is expected to grow in the forecasted period, in 2017 market size of the OTC Cough, Cold & Allergy Medicine was XX million and in 2025 is expected to reach at XX million with growing CAGR of XX%.

Market Dynamics:

Factor such as government initiatives, better healthcare facilities and increasing number of immunosuppressed individuals which are expected to boost the growth of the OTC Cough, Cold & Allergy Medicine Market. Furthermore, rising global geriatric population, laws enforcing consumer safety and increasing usage of cold & cough medications for minor issues is expected to boost the growth of the overall market. However, costs & prices with manufacturing process of the product are expected to hinder the growth of the OTC Cough, Cold & Allergy Medicine Market over the forecast period.

Market Players:

Sanofi-Aventis, Johnson & Johnson Service, Inc., Reckitt Benckiser Group Plc., Novartis AG, GlaxoSmithKline Plc., AstraZaneca Plc., Pfizer Inc., Sun Pharmaceutical Industries Ltd., Prestige Brands Holdings, Inc., Procter & Gamble Co., Bristol-Myers Squib Co., Merck & Co., and Allergenare some of the prominent players in the OTC Cough, Cold & Allergy Medicine Market.

 Request For Report Sample: https://www.researchreportinsights.com/report/upsample/120124650/OTC-Cough%2c-Cold-and-Allergy-Medicine-Market

Market Segmentation:

Asia-Pacificexpected to grow with a fastest CAGR over forecast period majorly due to government initiatives, dropping air quality which results in increase in pollution and higher occurrence of respiratory ailments.  Furthermore, rapid adoption of OTC medicines ,convenience of purchase and cost-efficiency is also expected to boost the growth of the overall market in this region.Countries such as China and Japan are expected to account for the largest market share over the forecast period.

Pharmacies segment of sales channel dominated the market in 2017 majorly due toincreasing sales of allergy, cold & cough drugs.

Market segmented on the basis ofdrugtype:

• Antihistamine

• Expectorants

• Bronchodilators

• Antibiotics

• Others

Market segmented on the basis ofsales channel:

• Pharmacy

• Online

• Modern Trade

• Drug Store

• Others

Request For Report TOC: https://www.researchreportinsights.com/report/TOC/120124650/OTC-Cough,-Cold-and-Allergy-Medicine-Market

Market segmented on the basis ofdosage:

• Liquid

• Capsule

• Tablet

• Lozenges

• Others

Market segmented on the basis of region:

- North America

• US

• Canada

• Mexico

- Europe

• UK

• Germany

• France

• Rest of Europe

- Asia-Pacific

• China

• Japan

• India

• Australia

• Rest of Asia-Pacific

- Latin America

• Brazil

• Rest of Latin America

- Middle East and Africa (MEA)

• South Africa

• Saudi Arabia

• Rest of MEA

Report Analysis: https://www.researchreportinsights.com/report/upcomming/120124650/OTC-Cough%2c-Cold-and-Allergy-Medicine-Market

Like Reblog Comment
text 2018-11-05 10:03
Nuclear Medicine Equipment Market

This report studies Nuclear Medicine Equipment in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
DDD Diagnostics A/S
Digirad Corporation
GE Healthcare
Philips Healthcare
Siemens Healthineers
Toshiba Medical Systems Corporation
...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
SPECT
Hybrid PET
Planar Scintigraphy

By Application, the market can be split into
Oncology
Cardiology
Neurology
General Imaging

By Regions, this report covers we can add the regions/countries as you want
North America
China
Europe
Southeast Asia
Japan
India

If you have any special requirements, please let us know and we will offer you the report as you want.

Source: www.qandqmarketresearch.com
Like Reblog Comment
show activity (+)
review 2018-10-26 21:46
The argument for palliative care
Being Mortal: Medicine and What Matters in the End - Atul Gawande

"...our decision making in medicine has failed so spectacularly that we have reached the point of actively inflicting harm on patients rather than confronting the subject of mortality. ...you live longer only when you stop trying to live longer." - pg 178

 

I wanted to start with that quote from today's book because it struck me as being so shocking in its simplicity and yet it completely blindsided me with its poignancy. Being Mortal: Medicine and What Matters in the End by Atul Gawande is at heart a discussion of the ups and downs of treating the elderly through a variety of means whether that means aggressive medicine, nursing homes, assisted living, or hospice. It's obvious that the author has a great admiration for palliative care and a belief that all doctors/clinicians should be trained and proactive to deliver the best care for their patients. In essence, asking practical questions about what trade-offs patients are willing to make for ensuring good days ahead are key to excellent palliative care (for any age). He stresses that instead of simply giving all the options for care at the outset of a diagnosis doctors should instead ask a set of pertinent questions to get at what their patient really wants to have a good quality of life. This is relevant (and necessary) for patients whether they be elderly, terminally ill, or disabled. Gawande clearly knows his stuff (he is a doctor after all) and he was thorough in his research for this book as he interviewed across many disciplines to see what is being done by various agencies in the care of the elderly and dying. Apparently there is no one accepted method of care except to ask, listen, and respect the wishes of patients. According to Gawande, there is "...a still unresolved argument about what the function of medicine really is - what, in other words, we should and should not be paying for doctors to do." (pg 187) Hospice is not just an option for those who are looking for end of life help or to speed up death but is an excellent choice to make good days out of one's remaining life. My verdict: Very informative book that I kept picking up with great alacrity and I will definitely read more of his writing. 10/10

 

I'll leave you with this final quote to chew over:

 

"At root, the debate is about what we fear most - the mistake of prolonging suffering or the mistake of shortening valued life. All the same, I fear what happens when we expand the terrain of medical practice to include actively assisting people with speeding their death." - pg 244  

 

What's Up Next: The Science of Superheroes by Lois H. Gresh & Robert E. Weinberg

 

What I'm Currently Reading: The Bear and the Nightingale by Katherine Arden

 

Source: readingfortheheckofit.blogspot.com
More posts
Your Dashboard view:
Need help?